Legend Biotech's Carvykti Is Taking Off, And It's Still Early (Rating Upgrade)
Carvykti's success boosts Legend Biotech Corporation's Q4 2024 sales to $334M, solidifying market position. Click to find out ...
I just learned how Wheel World's massive landscapes were made possible, and it's impressive
Wheel World is also a significant step up from developer Messhof's previous pixel art side-scrolling fighting game series ...
precisionmedicineonline21d
Cel-Sci to Initiate Phase III Trial of Immunotherapy in PD-L1-Low Head and Neck Cancer
NEW YORK – Cel-Sci on Thursday said it will initiate a Phase III registrational trial of its immunotherapy Multikine (leukocyte interleukin injection) in newly diagnosed, locally advanced head and ...
CNN-News1822d
Bayern Munich vs Celtic Live Football Streaming For Champions League Match: How to Watch BAY vs CEL Coverage on TV And Online
The BAY vs CEL Champions League match will be televised live on Sony Sports Network in India. How do I watch the Bayern Munich vs Celtic Champions League match live streaming? BAY vs CEL will be ...
Nasdaq27d
Allogene Therapeutics Announces Positive Phase 1 Results for Cema-Cel in Treating Relapsed/Refractory Large B-Cell Lymphoma
Allogene Therapeutics reports promising results for cema-cel, an allogeneic CAR T therapy for relapsed/refractory large B-cell lymphoma. Allogene Therapeutics has published promising results from ...
The New England Journal of Medicine29d
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
We describe two patients in whom malignant monoclonal T-cell lymphoproliferation developed after administration of chimeric antigen receptor (CAR) T-cell therapy with ciltacabtagene autoleucel ...